Effect of glucose-insulin-potassium in- fusion on mortality in patients with acute ST-segment elevation myocar- dial infarction: the CREATE-ECLA randomized controlled trial. JAMA. 2005;293:437 46. 572. van der Horst ICC, Zijlstra F, van t Hof AWJ, et al. Glucose-insulin- potassium infusion inpatients treated with primary angioplasty for acute myocardial infarction: the glucose-insulin-potassium study: a random- ized trial. J Am Coll Cardiol. 2003;42:784 91. 573. Selker HP, Beshansky JR, Sheehan PR, et al. Out-of-hospital administra- tion of intravenous glucose-insulin-potassium in patients with suspected acute coronary syndromes: the IMMEDIATE randomized controlled trial. JAMA. 2012;307:1925 33. 574. Newby LK, Eisenstein EL, Califf RM, et al. Cost effectiveness of early discharge after uncomplicated acute myocardial infarction. N Engl J Med. 2000;342:749 55. 575. Newby LK, Hasselblad V, Armstrong PW, et al. Time-based risk assess- ment after myocardial infarction: implications for timing of discharge and applications to medical decision-making. Eur Heart J. 2003;24:182 9. 576. Antman EM, Kuntz KM. The length of the hospital stay after myocardial infarction. N Engl J Med. 2000;342:808 10. 577. Th roux P, Waters DD, Halphen C, et al. Prognostic value of exercise testing soon after myocardial infarction. N Engl J Med. 1979;301:341 5. 578. Villella A, Maggioni AP, Villella M, et al. Prognostic significance of maximal exercise testing after myocardial infarction treated with throm- bolytic agents: the GISSI-2 data-base: Gruppo Italiano per lo Studio della Sopravvivenza Nell Infarto. Lancet. 1995;346:523 9. 579. Leppo JA, O Brien J, Rothendler JA, et al. Dipyridamole-thallium-201 scintigraphy in the prediction of future cardiac events after acute myo- cardial infarction. N Engl J Med. 1984;310:1014 8. 580. Hendel RC, Berman DS, Di Carli MF, et al. 